Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Dermatitis bullous Reports for Varicella (Varivax)
#10 most reported symptom for this vaccine
Dermatitis bullous and Varicella (Varivax)
Dermatitis bullous has been reported 5,234 times in association with Varicella (Varivax) vaccination in VAERS. This represents 5.6% of all 93,126 reports for this vaccine.
Among these reports, 4 mentioned death (0.08%) and 125 involved hospitalization (2.4%).
Dermatitis bullous is the #10 most frequently reported symptom for Varicella (Varivax) out of 2205 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
What This Means
Seeing 5,234 reports of Dermatitis bullous after Varicella (Varivax) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.08%, suggesting most cases are non-fatal.
Important Context
Quick Facts
Related Pages
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.